669 related articles for article (PubMed ID: 25248955)
1. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
[TBL] [Abstract][Full Text] [Related]
2. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
3. A comparative study: visual rating scores and the voxel-based specific regional analysis system for Alzheimer's disease on magnetic resonance imaging among subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Li F; Takechi H; Saito R; Ayaki T; Kokuryu A; Kuzuya A; Takahashi R
Psychogeriatrics; 2019 Mar; 19(2):95-104. PubMed ID: 30276926
[TBL] [Abstract][Full Text] [Related]
4. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
[TBL] [Abstract][Full Text] [Related]
5. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
Prasad K; Wiryasaputra L; Ng A; Kandiah N
Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
[TBL] [Abstract][Full Text] [Related]
6. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
[TBL] [Abstract][Full Text] [Related]
7. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
8. IVIG treatment of mild cognitive impairment due to Alzheimer's disease: a randomised double-blinded exploratory study of the effect on brain atrophy, cognition and conversion to dementia.
Kile S; Au W; Parise C; Rose K; Donnel T; Hankins A; Chan M; Ghassemi A
J Neurol Neurosurg Psychiatry; 2017 Feb; 88(2):106-112. PubMed ID: 26420886
[TBL] [Abstract][Full Text] [Related]
9. Predicting the conversion of mild cognitive impairment to Alzheimer's disease based on the volumetric measurements of the selected brain structures in magnetic resonance imaging.
Nesteruk M; Nesteruk T; Styczyńska M; Barczak A; Mandecka M; Walecki J; Barcikowska-Kotowicz M
Neurol Neurochir Pol; 2015; 49(6):349-53. PubMed ID: 26652867
[TBL] [Abstract][Full Text] [Related]
10. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
11. Cognitive reserve and the risk for Alzheimer's disease: a longitudinal study.
Serra L; Musicco M; Cercignani M; Torso M; Spanò B; Mastropasqua C; Giulietti G; Marra C; Bruno G; Koch G; Caltagirone C; Bozzali M
Neurobiol Aging; 2015 Feb; 36(2):592-600. PubMed ID: 25433459
[TBL] [Abstract][Full Text] [Related]
12. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
[TBL] [Abstract][Full Text] [Related]
13. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
[TBL] [Abstract][Full Text] [Related]
14. [Impact of combined medial temporal atrophy and white matter lesions on the cognitive and emotional functions in Alzheimer's disease patients].
Tokuchi R; Deguchi K; Yamashita T; Abe K
Nihon Ronen Igakkai Zasshi; 2014; 51(4):342-9. PubMed ID: 25327368
[TBL] [Abstract][Full Text] [Related]
15. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
[TBL] [Abstract][Full Text] [Related]
16. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
[TBL] [Abstract][Full Text] [Related]
17. Association between executive dysfunction and hippocampal volume in Alzheimer's disease.
Nagata T; Shinagawa S; Ochiai Y; Aoki R; Kasahara H; Nukariya K; Nakayama K
Int Psychogeriatr; 2011 Jun; 23(5):764-71. PubMed ID: 21106135
[TBL] [Abstract][Full Text] [Related]
18. Predicting conversion from mild cognitive impairment to Alzheimer's disease using brain
Mitolo M; Stanzani-Maserati M; Capellari S; Testa C; Rucci P; Poda R; Oppi F; Gallassi R; Sambati L; Rizzo G; Parchi P; Evangelisti S; Talozzi L; Tonon C; Lodi R; Liguori R
Neuroimage Clin; 2019; 23():101843. PubMed ID: 31071594
[TBL] [Abstract][Full Text] [Related]
19. Regional white matter lesions predict falls in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Ogama N; Sakurai T; Shimizu A; Toba K
J Am Med Dir Assoc; 2014 Jan; 15(1):36-41. PubMed ID: 24359699
[TBL] [Abstract][Full Text] [Related]
20. Utility of SPM8 plus DARTEL (VSRAD) combined with magnetic resonance spectroscopy as adjunct techniques for screening and predicting dementia due to Alzheimer's disease in clinical practice.
Waragai M; Hata S; Suzuki T; Ishii R; Fujii C; Tokuda T; Arai H; Ohrui T; Higuchi S; Yoshida M; Igarashi K; Moriya M; Iwai N; Uemura K
J Alzheimers Dis; 2014; 41(4):1207-22. PubMed ID: 24787913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
